Literature DB >> 8415915

In vivo fluorescence kinetics of phthalocyanines in a skin-fold observation chamber model: role of central metal ion and degree of sulfonation.

H L van Leengoed1, N van der Veen, A A Versteeg, R Ouellet, J E van Lier, W M Star.   

Abstract

The fluorescence pharmacokinetics of a series of metallosulfophthalocyanines, chelated with either aluminum or zinc and sulfonated to different degrees, was studied by fluorescence measurements in vivo. Dyes were administered systemically to female WAG/RIJ rats with an isogeneic mammary carcinoma transplanted into the subcutis in a transparent observation chamber located on their backs. Following an intravenous injection of 2.5 mumol/kg of the dye, fluorescence dynamics was observed up to 7 h postinjection. The phthalocyanines were excited at 610 nm with a power density of 0.1 mW/cm2 without causing photodynamic damage to the vasculature. Fluorescence was detected above 665 nm using a fluorescence imaging system based on an image intensifier. Dye retention in the blood vessels and tumor tissue was expressed as ratios relative to the fluorescence signal of the surrounding subcutaneous tissue. Phthalocyanines chelated with aluminum gave the highest fluorescence signal with tumor-over-subcutis ratios of up to a value of 4. The zinc complexes exhibited the highest vascular-over-subcutis ratios with maximum values exceeding a value of 6. They also displayed the longest retention times in the vascular system of well over 7 h. Overall, decreasing the degree of sulfonation of the metallophthalocyanines results in lower tumor-over-normal tissue fluorescence ratios, and furthermore aluminum-based dyes seem superior tumor localizers over zinc-based dyes. The advantages of phthalocyanines over porphyrins with respect to tumor localization and photodynamic therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415915     DOI: 10.1111/j.1751-1097.1993.tb09554.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  6 in total

1.  In vivo quantification of photosensitizer fluorescence in the skin-fold observation chamber using dual-wavelength excitation and NIR imaging.

Authors:  Slávka Kaščáková; Sebastiaan de Visscher; Bastiaan Kruijt; Henriëtte S de Bruijn; Angélique van der Ploeg-van den Heuvel; Henricus J C M Sterenborg; Max J H Witjes; Arjen Amelink; Dominic J Robinson
Journal:  Lasers Med Sci       Date:  2011-01-29       Impact factor: 3.161

2.  Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production.

Authors:  Pawel Mroz; Jayeeta Bhaumik; Dilek K Dogutan; Zarmeneh Aly; Zahra Kamal; Laiqua Khalid; Hooi Ling Kee; David F Bocian; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  Cancer Lett       Date:  2009-04-05       Impact factor: 8.679

3.  Phthalocyanine photosensitizers as contrast agents for in vivo photoacoustic tumor imaging.

Authors:  Amalina Bte Ebrahim Attia; Ghayathri Balasundaram; Wouter Driessen; Vasilis Ntziachristos; Malini Olivo
Journal:  Biomed Opt Express       Date:  2015-01-26       Impact factor: 3.732

4.  In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes.

Authors:  H L van Leengoed; V Cuomo; A A Versteeg; N van der Veen; G Jori; W M Star
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

5.  Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.

Authors:  Q Peng; J Moan
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

6.  Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.

Authors:  Henriette S de Bruijn; Vida Mashayekhi; Tom J L Schreurs; Pieter B A A van Driel; Gustav J Strijkers; Paul J van Diest; Clemens W G M Lowik; Ann L B Seynhaeve; Timo L M Ten Hagen; Jeanine J Prompers; Paul M P van Bergen En Henegouwen; Dominic J Robinson; Sabrina Oliveira
Journal:  Theranostics       Date:  2020-01-20       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.